Personalized Diagnostic Kit for Breast Cancer Patients Receives CE Mark

Like
Like Love Haha Wow Sad Angry

Personalized Diagnostic Kit for Breast Cancer Patients Receives CE Mark US-Dutch biotech Agendia has now received a CE Mark for its next-generation sequencing-based MammaPrint BluePrint breast cancer recurrence and molecular subtyping kit, allowing the firm to commercialize the device in Europe. This new device, which combines both MammaPrint and BluePrint, can aid physicians in personalizing […]

The post Personalized Diagnostic Kit for Breast Cancer Patients Receives CE Mark appeared first on BioTecNika .Read more at www.biotecnika.org/2018/03/personalized-diagnostic-kit-for-breast-cancer-patients-receives-ce-mark/

Like
Like Love Haha Wow Sad Angry

Related posts